VOICED : Investigadores britanicos ensayan vacuna contra el nuevo coronavirus en ratones

British researchers at Imperial College London are working on a coronavirus vaccine, aiming to be the first to conduct human clinical trials. They have begun testing the vaccine on mice to observe antibody responses. The coronavirus epidemic has claimed many lives in China since January. Researchers are leveraging past SARS studies to expedite vaccine development. Human trials may start soon, with a viable vaccine expected by year-end. Global efforts are underway to ensure the vaccine is safe and effective before mass production. For more details, visit ISGlobal.

What is the primary goal of the British researchers at Imperial College London?

• To study the effects of coronavirus on humans

• To create a vaccine for the new coronavirus

• To analyze the economic impact of the coronavirus

• To develop a treatment for the coronavirus

What previous research are professionals relying on to develop the coronavirus vaccine?

• Research on severe acute respiratory syndrome (SARS)

• Research on the common cold

• Studies on influenza

• Studies on the Ebola virus

What is the expected timeline for having a viable vaccine for human use?

• By next month

• In a couple of years

• In a few weeks

• By the end of the year

What must be demonstrated before a vaccine can be mass-produced?

• Its cost-effectiveness

• Its safety and efficacy

• Its popularity among researchers

• Its ability to be stored at room temperature

What is the main challenge in the global race to develop a coronavirus vaccine?

• Competition among pharmaceutical companies

• Finding enough volunteers for trials

• Lack of funding for research

• The lengthy process to ensure safety and efficacy